皮肤与性病威廉亚洲博彩公司

订阅

MedSci主页 / 所有栏目 / 皮肤与性病威廉亚洲博彩公司

2021 共识建议：中重度斑块型银屑病患者的达标治疗

2021-01-11 国外皮肤性病相关专家小组（统称） Dermatol Ther (Heidelb) . 2021 Jan 11.

银屑病

在一些严重的慢性疾病中应用达标治疗以改善结局，银屑病的治疗目标也被提出，但目前还没有针对目标达成共识，本文主要针对中重度斑块型银屑病患者的达标治疗提出专家共识建议。

中文标题：

2021 共识建议：中重度斑块型银屑病患者的达标治疗

英文标题：

Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations

发布机构：

国外皮肤性病相关专家小组（统称）

发布日期：

2021-01-11

简要介绍：

在一些严重的慢性疾病中应用达标治疗以改善结局，银屑病的治疗目标也被提出，但目前还没有针对目标达成共识，本文主要针对中重度斑块型银屑病患者的达标治疗提出专家共识建议。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 共识建议：中重度斑块型银屑病患者的达标治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=a54a31c0020a30fd, title=2021 共识建议：中重度斑块型银屑病患者的达标治疗, enTitle=Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations, guiderFrom=Dermatol Ther (Heidelb) . 2021 Jan 11., authorId=0, author=, summary=在一些严重的慢性疾病中应用达标治疗以改善结局，银屑病的治疗目标也被提出，但目前还没有针对目标达成共识，本文主要针对中重度斑块型银屑病患者的达标治疗提出专家共识建议。, cover=https://img.medsci.cn/2021125/1611505890004_2020535.jpg, journalId=0, articlesId=null, associationId=1324, associationName=国外皮肤性病相关专家小组（统称）, associationIntro=, copyright=0, guiderPublishedTime=Mon Jan 11 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>在一些严重的慢性疾病中应用达标治疗以改善结局，银屑病的治疗目标也被提出，但目前还没有针对目标达成共识，本文主要针对中重度斑块型银屑病患者的达标治疗提出专家共识建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=4418, tagName=银屑病)], categoryList=[CategoryDto(categoryId=39, categoryName=皮肤与性病, tenant=100), CategoryDto(categoryId=85, categoryName=威廉亚洲博彩公司 &解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=4418, guiderKeyword=银屑病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6950, appHits=165, showAppHits=0, pcHits=1069, showPcHits=6785, likes=3, shares=9, comments=16, approvalStatus=1, publishedTime=Mon Jan 25 00:35:07 CST 2021, publishedTimeString=2021-01-11, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Mon Jan 25 00:31:42 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 05:26:51 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 共识建议：中重度斑块型银屑病患者的达标治疗.pdf)])
2021 共识建议：中重度斑块型银屑病患者的达标治疗.pdf
下载请点击：
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1194509, encodeId=50041194509dc, content=hhegengengheniahenhao很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22375427291, createdName=ms8000000878452526, createdTime=Thu Feb 17 17:38:28 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190197, encodeId=5df9119019ea6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11cf4759545, createdName=142f8dc2m65暂无昵称, createdTime=Fri Feb 04 21:26:23 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062270, encodeId=304710622e0c4, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9745618539, createdName=ms3000000038296237, createdTime=Wed Oct 20 14:37:41 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057876, encodeId=2ba3105e876cb, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a1a5114704, createdName=14621e41m98暂无昵称, createdTime=Tue Oct 05 12:35:59 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051858, encodeId=e18f105185884, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 11:31:52 CST 2021, time=2021-09-16, status=1, ipAttribution=)]
    2022-02-17 ms8000000878452526

    hhegengengheniahenhao很好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1194509, encodeId=50041194509dc, content=hhegengengheniahenhao很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22375427291, createdName=ms8000000878452526, createdTime=Thu Feb 17 17:38:28 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190197, encodeId=5df9119019ea6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11cf4759545, createdName=142f8dc2m65暂无昵称, createdTime=Fri Feb 04 21:26:23 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062270, encodeId=304710622e0c4, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9745618539, createdName=ms3000000038296237, createdTime=Wed Oct 20 14:37:41 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057876, encodeId=2ba3105e876cb, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a1a5114704, createdName=14621e41m98暂无昵称, createdTime=Tue Oct 05 12:35:59 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051858, encodeId=e18f105185884, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 11:31:52 CST 2021, time=2021-09-16, status=1, ipAttribution=)]
    2022-02-04 142f8dc2m65暂无昵称

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1194509, encodeId=50041194509dc, content=hhegengengheniahenhao很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22375427291, createdName=ms8000000878452526, createdTime=Thu Feb 17 17:38:28 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190197, encodeId=5df9119019ea6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11cf4759545, createdName=142f8dc2m65暂无昵称, createdTime=Fri Feb 04 21:26:23 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062270, encodeId=304710622e0c4, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9745618539, createdName=ms3000000038296237, createdTime=Wed Oct 20 14:37:41 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057876, encodeId=2ba3105e876cb, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a1a5114704, createdName=14621e41m98暂无昵称, createdTime=Tue Oct 05 12:35:59 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051858, encodeId=e18f105185884, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 11:31:52 CST 2021, time=2021-09-16, status=1, ipAttribution=)]
    2021-10-20 ms3000000038296237

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1194509, encodeId=50041194509dc, content=hhegengengheniahenhao很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22375427291, createdName=ms8000000878452526, createdTime=Thu Feb 17 17:38:28 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190197, encodeId=5df9119019ea6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11cf4759545, createdName=142f8dc2m65暂无昵称, createdTime=Fri Feb 04 21:26:23 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062270, encodeId=304710622e0c4, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9745618539, createdName=ms3000000038296237, createdTime=Wed Oct 20 14:37:41 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057876, encodeId=2ba3105e876cb, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a1a5114704, createdName=14621e41m98暂无昵称, createdTime=Tue Oct 05 12:35:59 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051858, encodeId=e18f105185884, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 11:31:52 CST 2021, time=2021-09-16, status=1, ipAttribution=)]
    2021-10-05 14621e41m98暂无昵称

    学习学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1194509, encodeId=50041194509dc, content=hhegengengheniahenhao很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22375427291, createdName=ms8000000878452526, createdTime=Thu Feb 17 17:38:28 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190197, encodeId=5df9119019ea6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11cf4759545, createdName=142f8dc2m65暂无昵称, createdTime=Fri Feb 04 21:26:23 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062270, encodeId=304710622e0c4, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9745618539, createdName=ms3000000038296237, createdTime=Wed Oct 20 14:37:41 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057876, encodeId=2ba3105e876cb, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a1a5114704, createdName=14621e41m98暂无昵称, createdTime=Tue Oct 05 12:35:59 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051858, encodeId=e18f105185884, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 11:31:52 CST 2021, time=2021-09-16, status=1, ipAttribution=)]
    2021-09-16 湘雅科教

    受益匪浅

    0

以上为热门评论，williamhill asia 医学App还有更多内容

相关威廉亚洲博彩公司

2020 欧洲威廉亚洲博彩公司 ：寻常型银屑病的系统治疗—第1部分：治疗和监测建议

欧洲皮肤病与性病学会(EADV,European Academy of Dermatology and Venereology) · 2020-11-30

2020 BAD威廉亚洲博彩公司 ：银屑病生物治疗

英国皮肤科医师协会(BAD,British Association of Dermatologists) · 2020-03-18

中国银屑病生物治疗专家共识（2019）

中华医学会皮肤性病学分会 · 2019-12-30

生物反馈疗法调治银屑病专家共识（2019）

中国皮肤性病相关专家小组（统称） · 2019-09-02

2019 CDA实践威廉亚洲博彩公司 ：生物制剂治疗银屑病

国外皮肤性病相关专家小组（统称） · 2019-02-20

2019 AAD/NPF威廉亚洲博彩公司 ：银屑病伴意识和注意力合并症的管理的治疗

美国皮肤病学会(AAD,American Academy of Dermatology) · 2019-02-07

拓展阅读

银屑病及银屑病性关节炎的威廉亚洲博彩公司 ：第5部分.银屑病的光疗及光化学疗法的治疗威廉亚洲博彩公司 （AAD 2010）

美国皮肤病学会(AAD,American Academy of Dermatology) · 2010-01-01

2010 银屑病关节炎诊断及治疗威廉亚洲博彩公司

中华医学会风湿病学分会(CRA,Chinese Rheumatology Association) · 2010-09-01

银屑病及银屑病性关节炎的威廉亚洲博彩公司 ：第6部分.关于银屑病及银屑病性关节炎的治疗威廉亚洲博彩公司 ：基于病例及研究的结论（AAD 2011）

美国皮肤病学会(AAD,American Academy of Dermatology) · 2011-02-07

2011 EULAR共识：银屑病关节炎的药物治疗

欧洲抗风湿病联盟(EULAR,The European League Against Rheumatism) · 2011-09-27

2012 寻常性银屑病的常用外用药物治疗共识

中华医学会皮肤性病学分会 · 2012-04-30

2012 BSR/BHPR威廉亚洲博彩公司 ：应用生物制剂治疗银屑病关节炎

英国风湿病学会(BSR,British Society for Rheumatology) · 2013-07-25